CCM
SCMP

Consonance Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Consonance Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-925,214
Closed -$8.7M – 33
2013
Q4 		$8.7M Buy
925,214
+70,000
+8% +$499K 1.43% 21
2013
Q3 		$5.34M Buy
855,214
+675,226
+375% +$4.22M 1.33% 22
2013
Q2 		$1.18M Buy
+179,988
New +$1.43M 0.42% 18

Other funds holding SCMP

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Consonance Capital Management's SCMP Position: Q1 2014 in Review

Consonance Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2014, closing a stake of 925,214 shares — an estimated $8.7M sold.

Consonance Capital Management first reported a position in SCMP in Q2 2013 and held it in 3 quarters. The position peaked at $8.7M in Q4 2013. 81 funds tracked by Wall St. Rank hold SCMP as of Q1 2014.

  • Consonance Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Consonance Capital Management sold 925,214 Sucampo Pharmaceuticals, Inc. shares in Q1 2014, an estimated $8.7M.
  • Consonance Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • Consonance Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $8.7M in Q4 2013.
  • 81 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2014.

Based on Consonance Capital Management's 13F filing for Q1 2014, filed 15 May 2014.